Document Detail

Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy.
MedLine Citation:
PMID:  22559034     Owner:  NLM     Status:  Publisher    
Diabetic nephropathy (DN) is a leading disease that requires renal replacement therapy. The progression of renal dysfunction in DN is faster than the other renal diseases. While antihypertensive therapy reduces albuminuria, a good indicator for the progression, hypertension in DN is treatment resistant. Among patients with DN who took angiotensin receptor blockers (ARBs), 27 patients who exhibited poor control of albuminuria were enrolled into the study. Angiotensin receptor blocker was exchanged to aliskiren (150-300 mg/d) and clinical parameters were followed for 6 months. Exchange to aliskiren decreased albuminuria (1.57 ± 0.68 to 0.89 ± 0.45 g/gCr, P < .01) without changes in estimated glomerular filtration rate and office blood pressure (BP). Body weight and hemoglobin A1c were not altered. Aliskiren also reduced plasma renin activity (2.0 ± 0.9 to 1.2 ± 0.6 ng/mL/h, P < .01). While evening BP was unchanged, morning systolic BP (139 ± 8 to 132 ± 7 mm Hg, P < .01) and diastolic BP (81 ± 7 to 76 ± 6 mm Hg, P < .05) were decreased significantly after 6 months. Our results indicated that aliskiren decreased BP, especially morning BP in hypertensive patients with DN. The present data suggest that aliskiren exerts renoprotective actions including reduction in albumin excretion for patients with DN.
Tsuneo Takenaka; Kanako Nobe; Mika Okayama; Eriko Kojima; Yuka Nodaira; Keita Sueyoshi; Hitoshi Hoshi; Yusuke Watanabe; Hiroshi Takane; Hiromichi Suzuki
Related Documents :
12531914 - Characterization of cardiac hypertrophy and heart failure due to volume overload in the...
3011874 - Beta-adrenergic responses in drug-free subjects with asthma.
22559034 - Aliskiren reduces morning blood pressure in hypertensive patients with diabetic nephrop...
11889424 - Modulation of catecholamine responsiveness and beta-adrenergic receptor/adenylyl cyclas...
16946144 - Blood pressure changes during the initial week after different subtypes of ischemic str...
442944 - Regional lung function and central hemodynamics following normovolemic hemodilution in ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-4
Journal Detail:
Title:  Clinical and experimental hypertension (New York, N.Y. : 1993)     Volume:  -     ISSN:  1525-6006     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9305929     Medline TA:  Clin Exp Hypertens     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Nephrology, Saitama Medical University , Iruma, Saitama , Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Letter: Real-time, intercontinental dermatology teaching of trainee physicians in Somaliland using a...
Next Document:  Essential oils from Leptospermums of the Sunshine Coast and Northern Rivers Regions.